$46.39
-0.13 (-0.28%)
Gilead Sciences, Inc. (GILD)
CAPS Rating:
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.